Trevi Therapeutics, Inc.
NASDAQ:TRVI
6.31 (USD) • At close April 29, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current Assets: | |||||||||
| Cash & Cash Equivalents
| 34.097 | 32.397 | 12.589 | 36.83 | 45.001 | 57.313 | 17.165 | 22.02 | 8.286 |
| Short Term Investments
| 73.525 | 50.574 | 107.921 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 107.622 | 82.971 | 12.589 | 36.83 | 45.001 | 57.313 | 17.165 | 22.02 | 8.286 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0.265 | 0.558 | 0.184 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0.895 | 1.604 | 1.396 | 0.063 | 0 |
| Other Current Assets
| 1.806 | 4.576 | 2.106 | 0.886 | 1.003 | 1.681 | 1.438 | 0.142 | 0.106 |
| Total Current Assets
| 109.428 | 87.547 | 122.616 | 37.957 | 46.269 | 59.552 | 18.787 | 22.162 | 8.392 |
| Non-Current Assets: | |||||||||
| Property, Plant & Equipment, Net
| 1.229 | 1.559 | 0.194 | 0.184 | 0.33 | 0.43 | 0.149 | 0.014 | 0.005 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.243 | 0.297 | 0.205 | 0.334 | 0.532 | 0.019 | 1.553 | 0.052 | 0.012 |
| Total Non-Current Assets
| 1.472 | 1.856 | 0.399 | 0.518 | 0.862 | 0.449 | 1.702 | 0.066 | 0.017 |
| Total Assets
| 110.9 | 89.403 | 123.015 | 38.475 | 47.131 | 60.001 | 20.489 | 22.228 | 8.409 |
| Liabilities & Equity: | |||||||||
| Current Liabilities: | |||||||||
| Account Payables
| 3.414 | 1.809 | 2.857 | 2.849 | 2.016 | 1.599 | 0.603 | 0.537 | 0.445 |
| Short Term Debt
| 0.285 | 0.306 | 7.025 | 5.953 | 0.226 | 0.198 | 0 | 5.285 | 16.994 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 3.808 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 6.81 | 3.709 | 3.518 | 3.922 | 3.313 | 3.402 | 2.073 | 1.303 | 2.953 |
| Total Current Liabilities
| 10.509 | 5.824 | 13.4 | 12.724 | 5.555 | 5.199 | 2.676 | 7.125 | 20.392 |
| Non-Current Liabilities: | |||||||||
| Long Term Debt
| 0.747 | 1.032 | 2.153 | 8.676 | 14.098 | 0.257 | 1.142 | 0 | 5.117 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0.003 | 0 | 0.196 | 0 | 0.46 | 0.325 | 0.31 |
| Total Non-Current Liabilities
| 0.747 | 1.032 | 2.156 | 8.676 | 14.294 | 0.257 | 0.506 | 0.325 | 5.427 |
| Total Liabilities
| 11.256 | 6.856 | 15.556 | 21.4 | 19.849 | 5.456 | 3.182 | 7.45 | 25.819 |
| Equity: | |||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 60.001 | 115.742 | 99.206 | 54.743 |
| Common Stock
| 0.094 | 0.068 | 0.06 | 0.029 | 0.019 | 0.018 | 0.101 | 0.004 | 0.004 |
| Retained Earnings
| -287.045 | -239.134 | -210.069 | -180.917 | -146.977 | -114.219 | -109.498 | -84.432 | -72.157 |
| Accumulated Other Comprehensive Income/Loss
| 0.061 | -0.029 | -0.122 | 0 | 0 | -60.001 | -0.046 | -0.023 | -0 |
| Other Total Stockholders Equity
| 386.534 | 321.642 | 317.59 | 197.963 | 174.24 | 228.747 | 0 | 0 | 0 |
| Total Shareholders Equity
| 99.644 | 82.547 | 107.459 | 17.075 | 27.282 | 54.545 | 17.307 | 14.778 | -17.41 |
| Total Equity
| 99.644 | 82.547 | 107.459 | 17.075 | 27.282 | 54.545 | 17.307 | 14.778 | -17.41 |
| Total Liabilities & Shareholders Equity
| 110.9 | 89.403 | 123.015 | 38.475 | 47.131 | 60.001 | 20.489 | 22.228 | 8.409 |